MGLIX | TAREX | MGLIX / TAREX | |
Total Expense Ratio | 0.94 | 1.15 | 82% |
Annual Report Gross Expense Ratio | 0.95 | 1.17 | 81% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 3.616 | 7.712 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 10000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 350M | 633% |
Annual Yield % from dividends | 2.51 | 0.73 | 346% |
Returns for 1 year | 2.42 | 11.23 | 22% |
Returns for 3 years | -3.43 | 14.92 | -23% |
Returns for 5 years | 15.01 | 29.98 | 50% |
Returns for 10 years | 32.21 | -13.77 | -234% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMVX | 18.42 | 0.15 | +0.82% |
Voya Mid Cap Research Enhanced Index R | |||
OPTFX | 90.47 | 0.55 | +0.61% |
Invesco Discovery Large Cap A | |||
MUIGX | 17.56 | 0.07 | +0.40% |
Nationwide BNY Mellon Dyn US Core R6 | |||
GCVRX | 24.29 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R | |||
LHCTX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care R5 |